MARYLAND TECHNOLOGY DEVELOPMENT CENTER LICENSE AGREEMENT AMENDMENT 9

Exhibit 10.23

MARYLAND TECHNOLOGY DEVELOPMENT CENTER

LICENSE AGREEMENT

AMENDMENT 9

This addendum is made this 30 day of April, 2009, by and between MEDCO and Neogenix Oncology, Inc. (“Licensee”).

WHEREAS, MEDCO and Licensee have entered into a License Agreement dated April 28, 2004;

WHEREAS, Licensee currently occupies Labs #211 and #222, and offices #▇▇▇, #▇▇▇, #▇▇▇, #▇▇▇ and #317 in the Maryland Technology Development Center in ▇▇▇▇▇▇▇▇▇▇ County, Maryland (the “Original Premises”);

WHEREAS Licensee wishes to reduce its office space within the Maryland Technology Development Center and MEDCO is willing to provide for such reduction based on the terms provided for below;

NOW, THEREFORE, in consideration of the mutual covenants and agreements stated herein, the parties agree as follows:

1. Effective May 31, 2009, Licensee shall vacate office #132 (the “Reduction Premises”).

2. The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Reduction Premises provided for herein shall be as follows:

From June 1, 2009 to April 30, 2010		$	10,161
Renewal Term (if granted by MEDCO) From June 1, 2010 to April 30, 2011		$	11,177

3. All other provisions of the original License Agreement shall apply to this Amendment

This Amendment may be signed in counterparts.

FOR:		Maryland Economic Development Corporation				FOR:		Neogenix Oncology, Inc.
BY:		/s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇				BY:
		▇▇▇▇▇▇ Partners, Inc. Center Manager
Date:		5/22/09				Date:		4/30/09
BY:		/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
		▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ Executive Director, MEDCO
Date:		6/3/09